Skip to content
Madrigal Pharmaceuticals, Inc. Corporate Site
Contact Us
Search for:
MASH/NASH
Clinical Trials
Publications
Request Medical Information
Submit an Educational Grant Request
Investigator-Initiated Studies
Baseline characteristics in well-compensated NASH cirrhosis patients diagnosed with or without a liver biopsy in MAESTRO-NASH-OUTCOMES, a clinical outcome Phase 3 study assessing the effect of resmetirom in well-compensated NASH cirrhosis
Poster Presentation
File size: 372.96 KB
Created: 13-11-2024
Updated: 17-11-2024
Hits: 27
Download
Preview
Page load link
Go to Top